Date/Time: April 30, 2011 (Saturday); 9:00 AM – 4:30 PM

Location: McDonnell Douglas Auditorium, UC Irvine

Registration: http://sabpa.org/web/OCLA/

Fees (Breakfast and Lunch included): $30 for pre-registration (before April 25), $15 for students and post-docs, $40 for onsite registration

Sponsorship opportunities: please contact Yan-Bo Yang at Yan-Bo.Yang@bbraun.com

The upcoming annual biomedical forum will focus on FDA regulatory issues and the latest innovations in pharmaceutical and medical devices industries. The biomedical forum strives to provide an attractive platform for entrepreneurs, scientists, engineers, investors, executives, and policy makers to promote life sciences, biotech, medical device and alliances across the biomedical industry in Southern California and Asia.

Confirmed Speakers:

Alonza Cruse, Director, Los Angeles District Office, US FDA

“TBD”

Tom Yuen, Chairman and CEO, SRS Labs, Biomedical Entrepreneur

“Exploring the therapeutic application of stem cell technology: an entrepreneur’s journey”

Jeff Yuen, MPH, MBA, Previous FDA District Drug Team Leader and Drug Pre-Approval Manager, President and CEO, Jeff Yuen & Associates

“Recent FDA Regulatory Trends and Compliance Issues”

Shepard G. Bentley, RAC, Bentley & Liu Biomedical Consulting

“FDA Regulations and Chinese Manufacturers: The Challenges”

Paul Chen, MD, Entrepreneur and Eye Surgeon, North County Laser Eye Associates at San Diego

“JET Lasik, accelerating ocular healing by cell transplantation”

Steve Wheeler, Director of Sales, IDEAL LIFE

“The World-Wide Opportunities for Customized Wireless Monitoring with Real Time Data Access”

Fred Tzeng, PhD, President and Co-founder, ZeroWatt Technologies

“Commercialization of University Research by a Former Grad Student”

Nadine Ding, Fellow at Abbott Vascular Devices

“'Drug Eluting Stent, a Combination Product of Drug and Device and Its Regulatory Pathway”

Sabing Lee, JD, Knobbe, Martens, Olson & Bear, LLP

"Important Developments in Intellectual Property Affecting the Biomedical and Pharmaceutical Industries"

Edwards Sydney, Senior Director, Portfolio Management and Strategic Planning, Allergan

“Global Project & Portfolio Management: The Allergan Experience”